NCT00143182View on ClinicalTrials.gov

9 Week Extension Study of Asenapine and Olanzapine in Treatment of Mania (P07007)(COMPLETED)

PHASE3CompletedINTERVENTIONAL

Enrollment

504

Participants

Timeline

Start Date

January 7, 2005

Primary Completion Date

June 28, 2006

Study Completion Date

June 28, 2006

Conditions

Bipolar Disorder

Interventions

DRUG

Asenapine

Asenapine , 9 weeks

DRUG

Olanzapine

Olanzapine, 9 weeks

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Pfizer

INDUSTRY

lead

Organon and Co

INDUSTRY

NCT00143182 - 9 Week Extension Study of Asenapine and Olanzapine in Treatment of Mania (P07007)(COMPLETED) | Biotech Hunter | Biotech Hunter